Search - tctmd.com

Displaying 1 - 20 of 28

Sort: Relevancy | Date

News Conference News TCT 2022

Pre-AVR Cardiac Damage in PARTNER Patients Linked to Poorer QoL at 1 Year

L.A. McKeown

September 23, 2022

News Conference News TCT 2022

CCTA in Patients With Prior CABG Cuts Complications of Invasive Angio: BYPASS-CTCA

Yael L. Maxwell

September 21, 2022

Presentation TCT 2022

BPA for CTEPH: When and How?

Presenter: Vikas Aggarwal

September 19, 2022

Presentation TCT 2022

CTEPH? CTED? How Do We Make the Diagnosis?

Presenter: Riyaz Bashir

September 19, 2022

News Conference News TCT 2022

SYMPLICITY HTN-3’s Late Surprise: Sustained BP Drop at 3 Years Despite Earlier Miss

Michael O'Riordan

September 19, 2022

Presentation TCT 2022

NEXT STEPS: How Will Renal Denervation be Implemented in Practice?

Presenter: Naomi Fisher

September 18, 2022

Presentation TCT 2022

Clinical Implications of RADIANCE II and Recent Renal Denervation Trials: A Clinician’s Perspective

Presenter: Patrick O'Gara

September 18, 2022

Presentation TCT 2022

RADIANCE II: My Take-Home Messages

Presenter: Michel Azizi

September 18, 2022

News Conference News TCT 2022

RADIANCE II Confirms Ultrasound-Based Renal Denervation Lowers BP

Todd Neale

September 18, 2022

News Conference News TCT 2022

Pulmonary Artery Denervation in Idiopathic PAH Ups 6-Minute Walk Test

Shelley Wood

September 18, 2022

Presentation TCT 2022

Ultrasound Guidance for Vascular Access for Cardiac Procedures: A Randomized Trial (UNIVERSAL)

Presenter: Sanjit Jolly

September 18, 2022

Presentation TCT 2022

Outcomes for the Full US Cohort of the FLASH FlowTriever Mechanical Thrombectomy Registry in Pulmonary Embolism

Presenter: Catalin Toma

September 18, 2022

Presentation TCT 2022

Pulmonary Artery Denervation for Pulmonary Arterial Hypertension: A Sham-Controlled Randomised Trial

Presenter: ShaoLiang Chen

September 18, 2022

Presentation TCT 2022

Long-Term Outcomes Following Catheter-Based Renal Denervation in Patients With Uncontrolled Hypertension: 3-Year Follow-up of the SYMPLICITY HTN-3 Trial

Presenter: Deepak Bhatt

September 18, 2022

Presentation TCT 2022

Endovascular Ultrasound Renal Denervation to Treat Uncontrolled Hypertension: Primary Results of the Randomized, Sham-Controlled RADIANCE II Pivotal Trial

Presenter: Ajay Kirtane

September 18, 2022

News Conference News TCT 2022

TRILUMINATE Pivotal Trial: First Data Support Safety, Efficacy of TriClip

Caitlin E. Cox

September 17, 2022

Presentation TCT 2022

Continual Ambulatory Blood Pressure Monitoring System Will Change the Paradigm of Hypertension Care (Aktiia)

Presenter: Jay Shah

September 17, 2022

Presentation TCT 2022

Novel Devices to Treat Hypertension: What Else Should We Expect in the Near Future?

Presenter: Felix Mahfoud

September 17, 2022

Presentation TCT 2022

Update on the RADIANCE Clinical Trials Program (Ultra-Sound Renal Denervation)

Presenter: Naomi Fisher

September 17, 2022

Presentation TCT 2022

Update on the SPYRAL Clinical Trials Program (Radiofrequency Renal Denervation)

Presenter: David Kandzari

September 17, 2022

Advertisement

Pre-AVR Cardiac Damage in PARTNER Patients Linked to Poorer QoL at 1 Year

CCTA in Patients With Prior CABG Cuts Complications of Invasive Angio: BYPASS-CTCA

BPA for CTEPH: When and How?

CTEPH? CTED? How Do We Make the Diagnosis?

SYMPLICITY HTN-3’s Late Surprise: Sustained BP Drop at 3 Years Despite Earlier Miss

NEXT STEPS: How Will Renal Denervation be Implemented in Practice?

Clinical Implications of RADIANCE II and Recent Renal Denervation Trials: A Clinician’s Perspective

RADIANCE II: My Take-Home Messages

RADIANCE II Confirms Ultrasound-Based Renal Denervation Lowers BP

Pulmonary Artery Denervation in Idiopathic PAH Ups 6-Minute Walk Test

Ultrasound Guidance for Vascular Access for Cardiac Procedures: A Randomized Trial (UNIVERSAL)

Outcomes for the Full US Cohort of the FLASH FlowTriever Mechanical Thrombectomy Registry in Pulmonary Embolism

Pulmonary Artery Denervation for Pulmonary Arterial Hypertension: A Sham-Controlled Randomised Trial

Long-Term Outcomes Following Catheter-Based Renal Denervation in Patients With Uncontrolled Hypertension: 3-Year Follow-up of the SYMPLICITY HTN-3 Trial

Endovascular Ultrasound Renal Denervation to Treat Uncontrolled Hypertension: Primary Results of the Randomized, Sham-Controlled RADIANCE II Pivotal Trial

TRILUMINATE Pivotal Trial: First Data Support Safety, Efficacy of TriClip

Continual Ambulatory Blood Pressure Monitoring System Will Change the Paradigm of Hypertension Care (Aktiia)

Novel Devices to Treat Hypertension: What Else Should We Expect in the Near Future?

Update on the RADIANCE Clinical Trials Program (Ultra-Sound Renal Denervation)

Update on the SPYRAL Clinical Trials Program (Radiofrequency Renal Denervation)

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content